Read + Share
Amedeo Smart
Independent Medical Education
Zhu X, Callahan MF, Gruber KA, Szumowski M, et al. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia. J Clin Invest 2020 Jun 16. pii: 138392. doi: 10.1172/JCI138392.PMID: 32544087
Email
LinkedIn
Facebook
Twitter
Privacy Policy